The plot appears to have thickened in an NBC News investigation into problems related to the Recovery blood clot filter that C.R. Bard sold in the early part of the last decade.
NBC claims the filter, placed inside the vena cava to catch blood clots, was associated with 27 deaths and a couple hundred non-fatal problems—but Bard never recalled it.
Back in 2002, Bard hired veteran regulatory specialist Kay Fuller to help win approval for the Recovery, but she voiced concerns about the device after a small study raised red flags. Fuller tells NBC that Bard officials didn’t seem to want to hear her concerns, so she resigned and privately alerted FDA.
Help employers find you! Check out all the jobs and post your resume.
